Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-26-003424
Filing Date
2026-03-18
Accepted
2026-03-18 09:30:20
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-72528.html 3  
1 PRIMARY DOCUMENT marketforms-72528.xml 3 3971
2 POA DOCUMENT poa.htm EX-24 3585
  Complete submission text file 0001214659-26-003424.txt   9247
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Issuer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AM HASELNUSSSTRAUCH 14A MUNICH Germany 80935
Business Address
Merchant Ann Louise (Reporting) CIK: 0002116561 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37652 | Film No.: 26766224